TY - JOUR DO - 10.31373/ejtcm/95256 TI - Clinical and laboratory assessment of patients with new-onset atrial fibrillation in acute myocardial infarction T2 - European Journal of Translational and Clinical Medicine AU - Raczkowska-Golanko, Monika AU - Daniłowicz-Szymanowicz, Ludmiła AU - Nowak, Radosław AU - Puchalski, Wiesław AU - Gruchała, Marcin AU - Kozłowski, Dariusz AU - Raczak, Grzegorz PY - 2018 DA - 2018/10/01 PB - Medical University of Gdańsk SP - 39 EP - 43 VL - 1 IS - 1 KW - atrial fibrillation, acute myocardial infarction, NOAF LA - en AB - Background New-onset atrial fibrillation (NOAF) is one of the complications of acute myocardial infarction (AMI), and is associated with poor outcome. The aim of the study was clinical and laboratory assessment of patients with NOAF in AMI. Material and methods This is a retrospective, single-centre study of AMI patients with NOAF, who were admitted to Clinical Centre of Cardiology of the University Clinical Centre in Gdansk, from January 2016 to June 2018. The medical history, echocardiography parameters, AMI localization and infarcted-related artery as well as laboratory parameters at the admission and at the moment of NOAF onset were taken into further analyses. Results From 1155 consecutive AMI patients 103 (8.9%) with NOAF were enrolled into the study. A significant increase in C-reactive protein (CRP) and high-sensitive Troponine I (hsTnI) level, whereas significant decrease in potassium and hemoglobin level was observed at the moment of NOAF in comparison to admission. Conclusions Our study suggests that markers of inflammation (CRP), myocardial necrosis (hsTnI), hemoglobin and serum potassium may be associated with NOAF in the setting on AMI. The aforementioned parameters are generally available and may be used as an inexpensive and rapid way to select patients who are at high risk of developing NOAF. LK - https://ejtcm.gumed.edu.pl/articles/95256 UR - https://doi.org/10.31373/ejtcm/95256 ER -